参考文献/References:
[1]Armstrong DK,Alvarez RD,Backes FJ,et al.NCCN Guidelines Insights: Ovarian Cancer, Version 3.2022[J].Journal of the National Comprehensive Cancer Network,2022,20(9):972-980.[2]Mancari R,Cutillo G,Bruno V,et al.Development of new medical treatment for epithelial ovarian cancer recurrence[J].Gland Surgery,2020,9(4):1149-1163.[3]Kuroki L,Guntupalli SR.Treatment of epithelial ovarian cancer[J].BMJ (Clinical research ed),2020,371:m3773.[4]Ghafouri-Fard S,Shoorei H,Taheri M.miRNA profile in ovarian cancer[J].Experimental and Molecular Pathology,2020,113:104381.[5]Zhao H,Feng L,Cheng R,et al.miR-29c-3p acts as a tumorpromoter by regulating β-catenin signaling through suppressing DNMT3A, TET1 and HBP1 in ovarian carcinoma[J].Cellular signalling,2024,113:110936.[6]Tan S,Yu H,Zhang Z,et al.Hypoxic tumour-derived exosomal miR-1225-5p regulates M2 macrophage polarisation via toll-like receptor 2 to promote ovarian cancer progress[J].Autoimmunity,2023,56(1):2281226.[7]Liu L,Ning Y,Yi J,et al.miR-6089/MYH9/β-catenin/c-Jun negative feedback loop inhibits ovarian cancer carcinogenesis and progression[J].Biomedicine & Pharmacotherapy Biomedecine & Pharmacotherapie,2020,125:109865.[8]Wu X,Zhong Y,Zhang H,et al.MiR-5590-3p inhibits the proliferation and invasion of ovarian cancer cells through mediating the Wnt/β-catenin signaling pathway by targeting TNIK[J].Histology and Histopathology,2024,39(3):345-355.[9]Ling L,Wen Y,Chen H,et al.miR-134-3p driven by anisomycin impairs ovarian cancer stem cell activity through inhibiting GPR137 expression[J].Journal of Cancer,2023,14(18):3404-3015.[10]Zeng S,Liu S,Feng J,et al.MicroRNA-32 promotes ovarian cancer cell proliferation and motility by targeting SMG1[J].Oncology Letters,2020,20(1):733-741.[11]Garrido MP,Torres I,Avila A,et al.NGF/TRKA Decrease miR-145-5p Levels in Epithelial Ovarian Cancer Cells[J].Int J Mol Sci,2020,21(20):7657.[12]Zheng Q,Dai X,Fang W,et al.Overexpression of microRNA-367 inhibits angiogenesis in ovarian cancer by downregulating the expression of LPA1[J].Cancer Cell International,2020,20:476.[13]Hu X,Li J,Fu M,et al.The JAK/STAT signaling pathway: from bench to clinic[J].Signal Transduction and Targeted Therapy,2021,6(1):402.[14]Masoumi-Dehghi S,Babashah S,Sadeghizadeh M.microRNA-141-3p-containing small extracellular vesicles derived from epithelial ovarian cancer cells promote endothelial cell angiogenesis through activating the JAK/STAT3 and NF-κB signaling pathways[J].Journal of Cell Communication and Signaling,2020,14(2):233-244.[15]Park GB,Kim D.MicroRNA-503-5p Inhibits the CD97-Mediated JAK2/STAT3 Pathway in Metastatic or Paclitaxel-Resistant Ovarian Cancer Cells[J].Neoplasia,2019,21(2):206-215.[16]Zhang F,Luo BH,Wu QH,et al.LncRNA HCG18 upregulates TRAF4/TRAF5 to facilitate proliferation, migration and EMT of epithelial ovarian cancer by targeting miR-29a/b[J].Molecular Medicine,2022,28(1):2.[17]Kamdar RD,Harrington BS,Attar E,et al.NF-κB Signaling Modulates miR-452-5p and miR-335-5p Expression to Functionally Decrease Epithelial Ovarian Cancer Progression in Tumor-Initiating Cells[J].International Journal of Molecular Sciences,2023,24(9):7826.[18]Ma H,Qi G,Han F,et al.HMGB3 promotes the malignant phenotypes and stemness of epithelial ovarian cancer through the MAPK/ERK signaling pathway[J].Cell Communication and Signaling,2023,21(1):144.[19]Jia Y,Li J,Wang J,et al.Study on the Function and Mechanism of miR-585-3p Inhibiting the Progression of Ovarian Cancer Cells by Targeting FSCN1 to Block the MAPK Signaling Pathway[J].Analytical Cellular Pathology,2022,2022:1732365.[20]Fu Z,Ding C,Gong W,et al.ncRNAs mediated RPS6KA2 inhibits ovarian cancer proliferation via p38/MAPK signaling pathway[J].Frontiers in Oncology,2023,13:1028301.[21]Zhao W,Han T,Li B,et al.miR-552 promotes ovarian cancer progression by regulating PTEN pathway[J].Journal of Ovarian Research,2019,12(1):121.[22]Li L,He D,Guo Q,et al.Exosome-liposome hybrid nanoparticle codelivery of TP and miR497 conspicuously overcomes chemoresistant ovarian cancer[J].Journal of Nanobiotechnology,2022,20(1):50.[23]Zhang Q,Zhou X,Wan M,et al.FoxP3-miR-150-5p/3p suppresses ovarian tumorigenesis via an IGF1R/IRS1 pathway feedback loop[J].Cell Death & Disease,2021,12(3):275.[24]Yu JL,Gao X.MicroRNA 1301 inhibits cisplatin resistance in human ovarian cancer cells by regulating EMT and autophagy[J].European Review for Medical and Pharmacological Sciences,2020,24(4):1688-1696.[25]Fan L,Lei H,Zhang S,et al.Non-canonical signaling pathway of SNAI2 induces EMT in ovarian cancer cells by suppressing miR-222-3p transcription and upregulating PDCD10[J].Theranostics,2020,10(13):5895-5913.[26]Yao S,Gao M,Wang Z,et al.Upregulation of MicroRNA-34a Sensitizes Ovarian Cancer Cells to Resveratrol by Targeting Bcl-2[J].Yonsei Medical Journal,2021,62(8):691-701.[27]Jiang HW,Li L,Jiang P,et al.MicroRNA-489 targets XIAP to inhibit the biological progression of ovarian cancer via regulating PI3K/Akt signaling pathway and epithelial-to-mesenchymal transition[J].European Review for Medical and Pharmacological Sciences,2020,24(8):4113-4122.[28]Shao Y,Liu X,Meng J,et al.MicroRNA-1251-5p Promotes Carcinogenesis and Autophagy via Targeting the Tumor Suppressor TBCC in Ovarian Cancer Cells[J].Molecular Therapy,2019,27(9):1653-1664.[29]Li H,Lei Y,Li S,et al.MicroRNA-20a-5p inhibits the autophagy and cisplatin resistance in ovarian cancer via regulating DNMT3B-mediated DNA methylation of RBP1[J].Reproductive Toxicology,2022,109:93-100.[30]Hu Z,Cai M,Zhang Y,et al.miR-29c-3p inhibits autophagy and cisplatin resistance in ovarian cancer by regulating FOXP1/ATG14 pathway[J].Cell Cycle,2020,19(2):193-206.[31]Zhou Y,Wang C,Ding J,et al.miR-133a targets YES1 to reduce cisplatin resistance in ovarian cancer by regulating cell autophagy[J].Cancer Cell International,2022,22(1):15.[32]Yagi T,Sawada K,Miyamoto M,et al.Continuous Administration of Anti-VEGFA Antibody Upregulates PAI-1 Secretion from Ovarian Cancer Cells via miR-143-3p Downregulation[J].Molecular Cancer Research,2023,21(10):1093-1106.[33]Bustos MA,Yokoe T,Shoji Y,et al.MiR-181a targets STING to drive PARP inhibitor resistance in BRCA- mutated triple-negative breast cancer and ovarian cancer[J].Cell & Bioscience,2023,13(1):200.[34]Suzuki H,Yokoi A,Uno K,et al.Small Extracellular Vesicles from adipose-derived stem cells suppress cell proliferation by delivering the let-7 family of microRNAs in ovarian cancer[J].Biochemical and Biophysical Research Communications,2023,680:211-219.[35]Zeng J,Li YK,Quan FF,et al.Propofol induced miR-125a-5p inhibits the proliferation and metastasis of ovarian cancer by suppressing LIN28B[J] Molecular Medicine Reports,2020,22(2):1507-1517.[36]Liu LJ,Sun XY,Yang CX,et al.MiR-10a-5p restrains the aggressive phenotypes of ovarian cancer cells by inhibiting HOXA1[J].The Kaohsiung Journal of Medical Sciences,2021,37(4):276-285.[37]Chen R,Coleborn E,Bhavsar C,et al.miR-146a inhibits ovarian tumor growth in vivo via targeting immunosuppressive neutrophils and enhancing CD8+ T cell infiltration [J].Molecular Therapy Oncolytics,2023,31:100725.[38]Javanmardi S,Abolmaali SS,Mehrabanpour MJ,et al.PEGylated nanohydrogels delivering anti-MicroRNA-21 suppress ovarian tumor-associated angiogenesis in matrigel and chicken chorioallantoic membrane models[J].BioImpacts,2022,12(5):449-461.[39]Saiyed AN,Vasavada AR,Johar SRK.Recent trends in miRNA therapeutics and the application of plant miRNA for prevention and treatment of human diseases[J].Future Journal of Pharmaceutical Sciences,2022,8(1):24.[40]Meng Z,Lu M.RNA Interference-Induced Innate Immunity, Off-Target Effect, or Immune Adjuvant? [J].Frontiers in Immunology,2017,8:331.[41]Tang L,Bo H.The significance of studying functional lncRNA in mouse spermatogenesis[J].Epigenomics,2022,14(7):365-368.
相似文献/References:
[1]李淑惠.鲍曼不动杆菌临床分布及耐药性分析[J].医学信息,2018,31(03):165.[doi:10.3969/j.issn.1006-1959.2018.03.061]
LI Shu-hui.Clinical Distribution and Drug Resistance of Acinetobacter Baumannii[J].Journal of Medical Information,2018,31(07):165.[doi:10.3969/j.issn.1006-1959.2018.03.061]
[2]张丽琴,刘 婷,刘 聪,等.赣南地区临床分离菌耐药性变迁及多重耐药菌的流行变化[J].医学信息,2018,31(05):123.[doi:10.3969/j.issn.1006-1959.2018.05.043]
ZHANG Li-qin,LIU Ting,LIU Cong,et al.Changes of Drug Resistance of Clinical Isolates and Epidemic Changes of Multidrug-resistant Bacteria in Southern Guizhou[J].Journal of Medical Information,2018,31(07):123.[doi:10.3969/j.issn.1006-1959.2018.05.043]
[3]雷 敏.不孕不育患者解脲脲支原体培养及耐药性分析[J].医学信息,2018,31(06):156.[doi:10.3969/j.issn.1006-1959.2018.06.055]
LEI Min.Analysis of Culture and Drug Resistance of Ureaplasma Urealyticum in Infertility Patients[J].Journal of Medical Information,2018,31(07):156.[doi:10.3969/j.issn.1006-1959.2018.06.055]
[4]杨廷双.卵巢癌患者经CT检查和MRI检查的临床效果对比[J].医学信息,2018,31(07):153.[doi:10.3969/j.issn.1006-1959.2018.07.053]
YANG Ting-shuang.Comparison of Clinical Effects between CT and MRI in Patients with Ovarian Cancer[J].Journal of Medical Information,2018,31(07):153.[doi:10.3969/j.issn.1006-1959.2018.07.053]
[5]高程凤,孙 蕊.新生儿败血症致病菌分布及耐药性分析[J].医学信息,2018,31(17):116.[doi:10.3969/j.issn.1006-1959.2018.17.035]
GAO Cheng-feng,SUN Rui.Distribution and Drug Resistance of Pathogenic Bacteria in Neonatal Septicemia[J].Journal of Medical Information,2018,31(07):116.[doi:10.3969/j.issn.1006-1959.2018.17.035]
[6]张 美,王 欢,冯利芬.南京市江宁医院2015年~2017年血培养阳性病原菌分布及耐药性分析[J].医学信息,2018,31(20):108.[doi:10.3969/j.issn.1006-1959.2018.20.032]
ZHANG Mei,WANG Huan,FENG Li-fen.Analysis of Distribution and Drug Resistance of Blood Culture Positive Pathogens in Jiangning Hospital of Nanjing from 2015 to 2017[J].Journal of Medical Information,2018,31(07):108.[doi:10.3969/j.issn.1006-1959.2018.20.032]
[7]于文清.下呼吸道感染病原菌分布及耐药性分析[J].医学信息,2018,31(24):74.[doi:10.3969/j.issn.1006-1959.2018.24.019]
YU Wen-qing.Analysis of Distribution and Drug Resistance of Pathogenic Bacteria in Lower Respiratory Tract Infection[J].Journal of Medical Information,2018,31(07):74.[doi:10.3969/j.issn.1006-1959.2018.24.019]
[8]曾 江,邹 燕,刘 滨.耐甲氧西林金黄色葡萄球菌的临床分布及耐药性分析[J].医学信息,2019,32(02):148.[doi:10.3969/j.issn.1006-1959.2019.02.043]
ZENG Jiang,ZOU Yan,LIU Bin.Clinical Distribution and Drug Resistance Analysis of Methicillin-resistant Staphylococcus Aureus[J].Journal of Medical Information,2019,32(07):148.[doi:10.3969/j.issn.1006-1959.2019.02.043]
[9]彭 杰,张 琴.儿童呼吸内科下呼吸道分离菌分布及药敏分析[J].医学信息,2019,32(03):134.[doi:10.3969/j.issn.1006-1959.2019.03.043]
PENG Jie,ZHANG Qin.Distribution and Drug Sensitivity Analysis of Lower Respiratory Tract Isolates inChildren's Respiratory Medicine[J].Journal of Medical Information,2019,32(07):134.[doi:10.3969/j.issn.1006-1959.2019.03.043]
[10]揭嘉慧,张 颖.卵巢癌与非编码RNA研究进展[J].医学信息,2019,32(05):39.[doi:10.3969/j.issn.1006-1959.2019.05.014]
JIE Jia-hui,ZHANG Ying.Progress in Research on Ovarian Cancer and Non-coding RNA[J].Journal of Medical Information,2019,32(07):39.[doi:10.3969/j.issn.1006-1959.2019.05.014]
[11]施后渊,雷 明.离子通道与卵巢癌的相关性研究[J].医学信息,2021,34(09):48.[doi:10.3969/j.issn.1006-1959.2021.09.012]
SHI Hou-yuan,LEI Ming.Study on the Relationship Between Ion Channels and Ovarian Cancer[J].Journal of Medical Information,2021,34(07):48.[doi:10.3969/j.issn.1006-1959.2021.09.012]